Table 4 Tabular presentation for agreement of ROBIS results
From: A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2
Fibromyalgia review | Phase 2 | Phase 3 | |||
1. Study eligibility criteria | 2. Identification and selection of studies | 3. Data collection and study appraisal | 4. Synthesis and findings | 5. Risk of bias in the review | |
Homoeopathy | |||||
1. Perry | Low | Low | Low | Unclear | Low |
2. Boehm | High | Low | Low | High | High |
Acupuncture | |||||
3. Mayhew | Low | High | High | Low | Low |
4. Daya | Low | High | High | Low | Low |
5. Langhorst | Low | High | High | Low | Low |
6. Martin-Sanchez | Low | High | High | High | High |
7. Cao | Low | High | Low | Low | Low |
8. Deare | Low | Low | Low | Low | Low |
9. Yang | Low | Low | High | High | High |
Chiropractic | |||||
10. Ernst | High | Unclear | High | Unclear | Unclear |
Herbal Medicine | |||||
11. Nascimento | Low | Low | Low | High | Low |
Multiple CAM reviews | |||||
12. Holdcraft | Low | Low | Low | High | Low |
13. Baronowsky | Low | Low | Unclear | High | Low |
14. Terhorst | Low | High | Low | High | High |
15. De Silva | High | High | High | Unclear | Low |
Colic review | Phase 2 | Phase 3 | |||
1. Study eligibility criteria | 2. Identification and selection of studies | 3. Data collection and study appraisal | 4. Synthesis and findings | 5. Risk of bias in the review | |
Multiple CAM therapies | |||||
1. Perry | Low | Unclear | Low | Low | Low |
2. Bruyas-Bertholon | High | High | Unclear | High | High |
3. Harb | High | High | Low | High | High |
4. Gutierrez-Castrellon | Unclear | High | High | High | High |
Manipulation therapies | |||||
5. Dobson | Low | Low | Low | Low | Low |
6. Gleberzon | High | High | Unclear | Unclear | High |
7. Carne | Low | Low | Low | High | Unclear |
Acupuncture | |||||
8. Skejeie | Low | Low | Low | Low | Unclear |
Herbal medicine | |||||
9. Anheyer | Unclear | High | Low | High | High |
Probiotics | |||||
10. Sung 2013 | Unclear | Low | Low | High | Unclear |
11. Anabrees | Low | Low | Low | High | Low |
12. Urbansk | Low | High | High | High | High |
13. Xu | Unclear | Low | Low | Unclear | Low |
14. Shreck Bird | High | High | Low | High | High |
15. Dryl | High | High | Unclear | High | High |
16. Sung 2018 | High | Unclear | Unclear | Unclear | Unclear |